CANCER OF THE PANCREAS
Clinical trials for CANCER OF THE PANCREAS explained in plain language.
Never miss a new study
Get alerted when new CANCER OF THE PANCREAS trials appear
Sign up with your email to follow new studies for CANCER OF THE PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early test of engineered immune cells halted in pancreatic cancer fight
Disease control TerminatedThis early-phase study tested the safety of a new treatment called CAR T-cell therapy in adults with advanced pancreatic cancer that could not be removed by surgery. Doctors collected and modified patients' own immune cells to target cancer, then gave them back through an IV or d…
Matched conditions: CANCER OF THE PANCREAS
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Early cancer drug trial halted before full testing
Disease control TerminatedThis early-stage study tested a new oral drug called NUV-868, both alone and combined with two existing cancer medications (olaparib or enzalutamide), in adults with advanced solid tumors. The goal was to find safe doses and see if these treatments could help control cancers like…
Matched conditions: CANCER OF THE PANCREAS
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC